Searchable abstracts of presentations at key conferences in endocrinology

ea0058p010 | Bone | BSPED2018

Changes in bone mineral density from age 10 to 30 years in individuals with cystic fibrosis

Bucknall Thomas , Bucknall Catrin , Parsons Camille , Ward Kate , Legg Julian , Davies Justin H

Background: Osteoporosis and increased fracture risk associated with cystic fibrosis (CF) are becoming more relevant with improved life expectancy in this disease. The evolution of CF-related bone disease remains unclear.Aims: To evaluate change in bone mineral density (BMD) in individuals with CF from age 10 to 30 y.Methods: Data from the UK CF Trust registry, which contains anonymised clinical information, was used to evaluate BM...

ea0033oc1.6 | Oral Communications 1 | BSPED2013

Oral bisphosphonates as prophylaxis of steroid-induced osteoporosis in Duchenne muscular dystrophy

Srinivasan Ramesh , Rawlings David , Cheetham Tim , Sarkozy Anna , Bushby Kate , Owen Catherine

Background: Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy, resulting in death at a young age. Corticosteroids improve muscle function and slow disease progression. However long-term steroid therapy is a significant risk factor for osteoporosis.Aim: To assess the effect of oral bisphosphonate (risedronate) treatment on bone mineral density in a cohort of steroid-treated children with DMD.Method: Annual bone...

ea0033oc3.4 | Oral Communications 3 | BSPED2013

Successful Use of Long Acting Octreotide in Treatment of Congenital Hyperinsulinism

Shah Pratik , Gilbert Clare , Morgan Kate , Hinchey Louise , Senniappan Senthil , Arya Ved , Levy Hannah , Hussain Khalid

Introduction/Aim: Congenital hyperinsulinism (CHI) is a cause of severe hypoglycaemia in infancy. Treatment of diazoxide unresponsive patients includes the use of somatostatin analogues (octreotide given either as four s.c. injections daily or via a pump). We aimed to evaluate the use of a long acting somatostatin analogue (Lanreotide) in children with CHI, switching them from daily oral diazoxide or s.c. Octreotide injections to 4 weekly Lanreotide injections.<p class="ab...

ea0033p23 | (1) | BSPED2013

Can we prevent hypoglycaemic brain injuries in term babies with no risk factors of Hyperinsulinaemic Hypoglycaemia?

Gilbert Clare , Morgan Kate , Hinchey Louise , Shah Pratik , Kumaran Anitha , Hussain Khalid

Introduction: Hyperinsulinaemic hypoglycemia (HH) represents the most common cause of hyperinsulinism in neonates, often termed as congenital hyperinsulinism of infancy (CHI). CHI is characterised by inappropriate raised insulin secretion from the pancreatic β-cells in relation to blood glucose concentration. Insulin suppresses NEFA and BOHB production. Neurological damage is a known risk associated with hyperinsulinaemic hypoglycaemia (HH).Aim: To ...

ea0028p283 | Reproduction | SFEBES2012

Androgens stimulate growth of mouse preantral follicles in culture

Connolly Jennifer , Tremaine Tina , Mora Jossie , Fenwick Mark , Hardy Kate , Franks Stephen

Polycystic ovary syndrome is the commonest cause of anovulation. The mechanism of the aberrant follicle development that is associated with anovulation remains unclear. However, data from human studies and from animal models of PCOS suggest that excess androgen production, the biochemical hallmark of PCOS, has a role in disordered follicle development. The aim of this study was to examine the direct effect of androgens on isolated mouse preantral follicles in culture. Multilay...

ea0025p276 | Reproduction | SFEBES2011

Defining insulin signalling pathways in granulosa-lutein (GL) cells in women with polycystic ovary syndrome (PCOS)

Joharatnam Jalini , Lamanna Giuseppina , Trew Geoffrey , Lavery Stuart , Hardy Kate , Franks Stephen

Aim: PCOS is associated with peripheral insulin resistance and we have previously shown that glucose uptake and metabolism are impaired in granulosa lutein (GL) cells of anovulatory women with PCOS (anovPCO). The aim of this study was to delineate insulin-signalling pathways in GL cells from women with anovPCO and to compare the response to insulin with that in GL cells from ovulatory women with (ovPCO) and without polycystic ovaries (controls).Methods: ...

ea0025p330 | Thyroid | SFEBES2011

Should individuals with a Thy 3 result always undergo surgery?

Green Jessica , Hunt Toby , Mukhtar Rasha , Ward Alexandra , Allen Kate , Robinson Anthony , Maddox Paul

Introduction: British Thyroid Association Guidelines state that the diagnosis of thyroid malignancy cannot be based on the results of an aspiration’s cytology alone and will usually require surgical removal for confirmation. There has been much debate about the management of indeterminate fine needle aspirations (Thy 3). Recent publications have reported that the prevalence of thyroid carcinoma following a Thy 3 result to be as high has 28%, emphasising the importance of ...

ea0021p93 | Clinical practice/governance and case reports | SFEBES2009

Reasons for treatment changes in hypogonadal men undergoing testosterone replacement

Dutton David , Outterside Kate , Padinjakara Rayin , Weickert Martin , Randeva Harpal , Sankar Sailesh

Aims: Treatment regimes for low testosterone are well established but reasons for treatment change and patient preferences are less well known. We looked at the type of testosterone replacement, subsequent modification of replacement and reason for that change.Methods: Data were collected from the electronic case notes of 50 patients on testosterone replacement for at least 6 months attending endocrine clinics in a University Teaching Hospital.<p cla...

ea0021p267 | Pituitary | SFEBES2009

Endocrine outcomes of pituitary surgery

Millar Kate , Dissanayake Sanjaya , Ghosh Kaushik , Kaimal Nisha , Walmsley David , Kaushal Kalpana , Howell Simon

Transphenoidal surgery is an effective treatment option in patients with pituitary tumours associated with compression of the optic chiasm or hormone hypersecretion. Surgery carries with it a risk of the development of new pituitary hormone deficits but also the potential for recovery of existing pituitary hormone deficits. We have examined data concerning pituitary function in 80 patients who underwent endoscopic transphenoidal pituitary surgery at Royal Preston Hospital....

ea0015p341 | Thyroid | SFEBES2008

Specialist endocrine care for all hyperthyroid patients?

Evans Kate , Coupe Aileen , Mascas Ramona , Pilianidis George , Foote John , Browne Duncan , Pinkney Jon

Objectives: To establish the proportion of patients locally with potentially significant thyroid pathology not receiving specialist endocrine input. To look at the management of hyperthyroid patients within the Endocrinology service.Patients and methods: Utilising the laboratory database, 121 patients identified (97 female, 24 male; age range 17–93 years, average 55 years) with TFTs suggesting hyperthyroidism (raised fT4/fT3, and/or suppressed TSH) ...